[Retracted] microRNA‑485 inhibits the malignant behaviors of retinoblastoma by directly targeting Wnt3a
- PMID: 35703344
- PMCID: PMC9245064
- DOI: 10.3892/or.2022.8347
[Retracted] microRNA‑485 inhibits the malignant behaviors of retinoblastoma by directly targeting Wnt3a
Abstract
Following the publication of the above paper, the authors submitted a request to the Editorial Office to retract the article on account of the fact that the ethical approval for the tumor xenograft experiments performed in mice, as shown in Fig. 7, had not been obtained from their hospital; consequently, all authors were in agreement that the article should be retracted to ensure the integrity of the scholarly record. Independently of this request, it was also drawn to the Editor's attention by a concerned reader that data in several of the figures were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that there were contentious data in the above article that had already been published prior to its submission to Oncology Reports, and after assessing the authors' request, the Editor concurs that this paper should be retracted from the Journal. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 41: 3137-3147, 2019; DOI: 10.3892/or.2019.7061].
Keywords: Wnt3a; apoptosis; metastasis; microRNA‑485; proliferation; retinoblastoma.
Retraction of
-
microRNA‑485 inhibits the malignant behaviors of retinoblastoma by directly targeting Wnt3a.Oncol Rep. 2019 May;41(5):3137-3147. doi: 10.3892/or.2019.7061. Epub 2019 Mar 13. Oncol Rep. 2019. Retraction in: Oncol Rep. 2022 Aug;48(2):136. doi: 10.3892/or.2022.8347. PMID: 30896857 Retracted.
Similar articles
-
[Retracted] MicroRNA‑485 plays tumour‑suppressive roles in colorectal cancer by directly targeting GAB2.Oncol Rep. 2022 Apr;47(4):63. doi: 10.3892/or.2022.8274. Epub 2022 Jan 28. Oncol Rep. 2022. PMID: 35088894 Free PMC article.
-
[Retracted] MicroRNA‑485 targets MACC1 and inhibits cervical cancer cell proliferation and invasion.Mol Med Rep. 2023 Jan;27(1):1. doi: 10.3892/mmr.2022.12888. Epub 2022 Nov 2. Mol Med Rep. 2023. PMID: 36321784 Free PMC article.
-
[Retracted] MicroRNA‑675 inhibits cell proliferation and invasion in melanoma by directly targeting metadherin.Mol Med Rep. 2023 May;27(5):99. doi: 10.3892/mmr.2023.12986. Epub 2023 Mar 31. Mol Med Rep. 2023. PMID: 36999591 Free PMC article.
-
[Retracted] Synergistic effects of co‑expression plasmid‑based ADAM10‑specific siRNA and GRIM‑19 on hepatocellular carcinoma in vitro and in vivo.Oncol Rep. 2022 Feb;47(2):24. doi: 10.3892/or.2021.8235. Epub 2021 Nov 29. Oncol Rep. 2022. PMID: 34841439 Free PMC article.
-
[Retracted] miR‑124 inhibits proliferation and invasion of human retinoblastoma cells by targeting STAT3.Oncol Rep. 2021 Nov;46(5):242. doi: 10.3892/or.2021.8193. Epub 2021 Sep 24. Oncol Rep. 2021. PMID: 34558651 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources